home / stock / crpof / crpof short
Short Information | Ceapro Inc (OTCMKTS:CRPOF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 65,920 |
Total Actual Volume | 215,045 |
Short Trends | |
---|---|
Cover Days | 5 |
Short Days | 14 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 3,296 |
Average Short Percentage | 73.28% |
Is there a CRPOF Short Squeeze or Breakout about to happen?
See the CRPOF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
03-26-2024 | $0.1669 | $0.1669 | $0.1669 | $0.1669 | 5,000 | 5,000 | 100% |
03-06-2024 | $0.16758 | $0.16758 | $0.16758 | $0.16758 | 10,000 | 10,000 | 100% |
02-28-2024 | $0.155 | $0.16 | $0.1611 | $0.153 | 20,220 | 8,100 | 40.06% |
02-27-2024 | $0.1613 | $0.155 | $0.1613 | $0.155 | 61,500 | 7,000 | 11.38% |
02-26-2024 | $0.17705 | $0.1564 | $0.17705 | $0.1564 | 41,570 | 6,250 | 15.03% |
02-16-2024 | $0 | $0.13062 | $0 | $0 | 15 | 15 | 100% |
02-09-2024 | $0.124 | $0.1318 | $0.1318 | $0.124 | 5,200 | 200 | 3.85% |
02-02-2024 | $0 | $0.124 | $0 | $0 | 7,500 | 7,500 | 100% |
02-01-2024 | $0.124 | $0.124 | $0.124 | $0.124 | 1,000 | 1,000 | 100% |
01-29-2024 | $0.11464 | $0.11464 | $0.11464 | $0.11464 | 430 | 430 | 100% |
01-16-2024 | $0.14 | $0.1301 | $0.14 | $0.1301 | 8,299 | 1,983 | 23.89% |
01-12-2024 | $0.135 | $0.1441 | $0.1442 | $0.135 | 20,266 | 14,717 | 72.62% |
01-11-2024 | $0.135 | $0.135 | $0.135 | $0.134951 | 31,900 | 1,600 | 5.02% |
01-09-2024 | $0.135 | $0.135 | $0.135 | $0.135 | 300 | 300 | 100% |
01-08-2024 | $0.1399 | $0.1399 | $0.1399 | $0.1399 | 300 | 300 | 100% |
01-03-2024 | $0.1489 | $0.1489 | $0.1489 | $0.1489 | 300 | 300 | 100% |
01-02-2024 | $0.1588 | $0.1588 | $0.1588 | $0.1588 | 320 | 300 | 93.75% |
12-29-2023 | $0 | $0.1652 | $0 | $0 | 25 | 25 | 100% |
12-28-2023 | $0.1652 | $0.1652 | $0.1652 | $0.1652 | 200 | 200 | 100% |
12-26-2023 | $0.163 | $0.163 | $0.163 | $0.163 | 700 | 700 | 100% |
News, Short Squeeze, Breakout and More Instantly...
– 2023 marked by Ceapro’s achievement of key milestones and progress toward its next phase of growth – R&D activities focused on advancement of avenanthramide Phase 1-2a clinical study and the processing of yeast beta glucan along with the building of pi...
TORONTO and EDMONTON, Alberta, March 28, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) ("Aeterna") and Ceapro ...
TORONTO and EDMONTON, March 28, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (" Aeterna ") and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“ Ceapro ”) are pleased to announce that the Court of King's Bench of Alberta has issued a final order approvin...